AMGN vs ZBH
By Alex · Tickerpine
Amgen Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | ZBH |
|---|---|---|
| Price | $416.18 | $97.89 |
| Market cap | $225.15B | $18.67B |
| P/E ratio | 25.7 | 23.6 |
| ROE | 91.47% | 6.41% |
| Profit margin | 22.95% | 9.48% |
| Revenue growth | 9.50% | 4.80% |
| Dividend yield | 2.43% | 0.98% |
| Beta | 0.41 | 0.46 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs ZBH in plain English
- AMGN is the bigger company — about 12.1× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 23.6 vs 25.7).
- AMGN earns a higher return on equity (91% vs 6%).
- AMGN is growing revenue faster (10% vs 5%).
- AMGN has the higher dividend yield (2.43% vs 0.98%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.